For its part, Hims & Hers maintains that the 'Sick of the System' ad – its first for a Super Bowl – "highlights the growing ...

Europe to review safety data for Eisai-Biogen Alzheimer's drug January 31, 2025 Veru said on Monday its experimental drug in combination with Novo ... to a research letter published on Friday.

Kenya Medical Training College, in partnership with UNHCR, has announced 50 Community Health Nursing scholarships for Turkana residents and refugees.

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...

While Novo’s type 2 diabetes GLP-1 Ozempic has largely stolen the show in recent years, obesity med Wegovy—which utilizes the same molecule semaglutide at higher doses than Ozempic ...

LONDON/COPENHAGEN, Feb 5 (Reuters) - Novo Nordisk emissions grew 23% in 2024, the company said on Wednesday, and will keep rising through the end of the decade as it boosts production of ...

Novo Nordisk’s CEO toasted the company’s record-breaking profitability and earnings on Wednesday morning as the group behind Ozempic and Wegovy put on a brave face about its ability to fight ...

Danish drugmaker Novo Nordisk on Wednesday posted another quarter of rapid profit growth, though the story for once wasn’t its wildly popular weight-loss drugs. Novo Nordisk said its fourth ...

Shares of Denmark’s Novo Nordisk (NOV: N) rose 3.5% to 613.30 kroner this morning ... data analyses and commentary from our global network of life sciences reporters. Receive The Pharma Letter daily ...